DOV Pharmaceuticals has announced that dosing has been suspended in its ongoing trial of ocinaplon due to liver enzyme elevations

By  

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Alexza Pharmaceuticals has announced that it has completed enrolment in its second phase III trial with loxapine

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Encysive Pharmaceuticals has announced the launch of sitaxentan [Thelin] in France for the treatment of pulmonary arterial hypertension

By  

Inpharma, Vol. 1, Iss. 1610, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Rifaximin may have a dramatic effect on hepatic encephalopathy

By Lamb Christopher A   Reddy Anand V  

Clinical Medicine, Vol. 12, Iss. 5, 2012-10 ,pp. : 489-490

Royal College Of Physicians

Access to resources Recommend Favorite

Rifaximin improves QoL in hepatic encephalopathy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 603, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite